MET and metastatic neoplasm: On the contrary, the median time to distant metastasis for those with negative MET expression was longer than that with mild expression (Figure 2b), which is in line with the known role of MET in the development of metastatic disease at distant sites, as demonstrated in several malignancies [26,27,28,29,30].